
Pharma Pulse 3/17/25: Dual Trial Strategies, Executive Order Advances Price Transparency Efforts & more
Dual Trial Strategy: Company-Sponsored and Investigator-Initiated Artiva Biotherapeutics' CEO Fred Aslan, MD, explains the strategic advantages of pursuing both a company-sponsored trial and an investigator-initiated trial simultaneously. Executive …